tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Holding ENTA?
Track your performance easily

Enanta Pharmaceuticals (ENTA) Income Statement

160 Followers

Enanta Pharmaceuticals Income Statement

Last quarter (Q4 2024), Enanta Pharmaceuticals's total revenue was $14.61M, a decrease of -17.92% from the same quarter last year. In Q4, Enanta Pharmaceuticals's net income was $-28.82M. See Enanta Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 69.47M$ 67.64M$ 79.20M$ 86.16M$ 97.07M$ 122.47M
Cost of Revenue
-----$ -164.11M
Gross Profit
$ 69.47M$ 67.64M$ 79.20M$ 86.16M$ 97.07M$ 122.47M
Operating Expense
$ 195.11M$ 189.33M$ 216.41M$ 210.00M$ 206.65M$ 164.11M
Operating Income
$ -125.64M$ -121.69M$ -137.21M$ -123.84M$ -109.57M$ -41.64M
Net Non Operating Interest Income Expense
$ 3.86M-$ 6.21M$ 1.57M$ 2.02M$ 6.47M
Other Income Expense
$ -14.77M$ -14.77M$ -11.36M$ 83.00K$ 27.00K$ -149.00K
Pretax Income
$ -121.11M$ -117.79M$ -131.00M$ -122.19M$ -107.58M$ -35.02M
Tax Provision
$ 2.84M$ -1.74M$ 2.82M$ -433.00K$ -28.58M$ 1.15M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -123.95M$ -116.05M$ -133.82M$ -121.75M$ -79.00M$ -36.17M
Basic EPS
$ -5.87$ -5.48$ -6.38$ -5.91$ -3.92$ -1.81
Diluted EPS
$ -5.87$ -5.48$ -6.38$ -5.91$ -3.92$ -1.81
Basic Average Shares
$ 63.32M$ 21.16K$ 20.97K$ 20.60K$ 20.17M$ 19.94M
Diluted Average Shares
$ 63.32M$ 21.16K$ 20.97K$ 20.60K$ 20.17M$ 19.94M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 195.11M$ 189.33M$ 216.41M$ 210.00M$ 206.65M-
Net Income From Continuing And Discontinued Operation
$ -123.95M$ -116.05M$ -133.82M$ -121.75M$ -79.00M$ -36.17M
Normalized Income
$ -87.65M$ -119.53M----
Interest Expense
------
EBIT
$ -113.32M$ -117.79M$ -131.00M$ -122.19M$ -107.58M$ -41.64M
EBITDA
$ -109.91M$ -115.45M$ -128.62M$ -119.22M$ -104.25M$ -37.99M
Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis